ARCHIVES

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

Additional DCE Contract Concepts

November 16, 1984

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

President’s FY 1987 Budget Trims NCI 473 Million From 1986 Appropriation; Basic Research Hit Hard

February 7, 1986

AACR Receives Record Number of Abstracts

January 27, 1989

HHS Forms Patient Safety Task Force; Henry Ford Health System Receives $40M.

April 27, 2001

Biotheraputices To Reveal Plans for Expansion

August 8, 1986